![]() This combined lab company was renamed Solstas Lab Partners in February, 2011. ![]() In the past 18 months, it purchased both Spectrum Laboratory Network and Carilion Laboratories. Welsh, Carson, Anderson, & Stowe is one such private equity company. These are typically private equity firms and investment companies whose executives see laboratory testing as a top investment opportunity. Some financial analysts say it is now a “seller’s market” for clinical lab and pathology group sales.īut in recent years, private buyers have regularly participated in bidding for lab testing companies that come to market. ( ASX:SHL), continue to bid strongly-particularly for laboratory organizations they deem have the highest strategic value for their business. The nation’s largest publicly traded lab firms, which include Quest Diagnostics Incorporated ( NYSE:DGX), Laboratory Corporation of America ( NYSE:LH), and Sonic Healthcare Ltd. In fact, the diversity of buyers illustrates why the prices paid for select lab companies in recent sales have been so strong. Both are reasons why some financial analysts say it is now a “seller’s market” for clinical lab and pathology group sales.ĭiversity of Buyers for Clinical and Pathology Laboratories Several factors reinforce this optimistic prediction.įirst, on the buy side, there is both strong demand for established laboratory companies and a growing number of motivated buyers. That’s because buyers have stepped up and paid strong prices for the medical laboratory companies and pathology testing firms that came to market during this time.Įxperts predict that merger and acquisition (M&A) activity in the clinical laboratory industry will continue to be robust. Conference on May 5 about clinical laboratory and pathology mergers and acquisitionsįor owners and sellers of clinical laboratories and anatomic pathology groups in the United States, the past six months have been rosy times. ![]()
0 Comments
Leave a Reply. |